What MyAlyce does

MyAlyce Inc. is a Los Angeles-based, privately held healthcare technology company that operates Beora, a recovery support platform targeted at individuals recovering from substance use disorders and mental health conditions, and the treatment providers and healthcare systems that serve them. The company was founded in 2023 with backing from the Evergreen Fund and operates with a team of 1–10 employees.

Beora's core offering combines wearable biometric technology with an LLM-Wiki software architecture. The LLM-Wiki functions as a patient's living record, synthesizing inputs from electronic medical records (EMRs), AI agent conversations, biometric vitals, and clinical events into an append-only, source-traceable record that operates above — not in place of — existing EMR systems. The platform uses a three-tier context model (client-safe, staff-only, clinical) to manage data access and privacy, and is structured around a 12-dimension recovery framework intended to address post-discharge disconnection in the substance use and mental health treatment continuum.

The company's go-to-market is an enterprise field-sales motion targeting treatment facilities and healthcare systems, currently in an early-access stage with no public pricing or named customers. Revenue mechanics are presumed to involve recurring software subscriptions, potentially bundled with wearable hardware, though no specific pricing model, contract structure, or revenue figures have been disclosed. No healthcare-specific certifications, regulatory clearances, partnerships, or named customers are present in the available data, representing material diligence gaps for any investor evaluation.

Name

MyAlyce

Legal name

MyAlyce Inc.

Website

https://myalyce.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

1. Software and Wearable Technology Platform: Company provides wearable technology and software for people in recovery from substance use and mental health challenges. Revenue likely derived from healthcare provider partnerships and possibly recurring software subscriptions, though specific model not disclosed.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

MyAlyce sells Beora, a recovery support platform that pairs wearable biometric technology with an LLM-Wiki software layer to support individuals in substance use and mental health recovery. The platform synthesizes data from EMRs, AI agent conversations, vitals, and clinical events into an append-only living patient record, and is sold primarily to treatment providers and healthcare systems via an early access program.

Product overview

MyAlyce operates Beora as its primary product — a unified recovery support platform combining wearable technology and software. The platform's core component is the LLM-Wiki, which synthesizes patient data from EMR systems, agent conversations, vitals, and clinical events into an append-only living record. Beora is designed to maintain continuous connection with individuals post-treatment through its '12 dimension wheel' framework, moving beyond episodic treatment to a persistent recovery support system.

Differentiator

Problem solved

Functional benefit

Brands

• Beora: A second brain for people in recovery—staying with users across treatment, community, and the years in between. An LLM-Wiki serving as the patient's living record drawn from EMR, agent conversations, vitals, and clinical events.

Products and services

• Beora Beora is a recovery support platform that combines wearable biometric technology with an LLM-Wiki software layer to support individuals in substance use and mental health recovery. It synthesizes EMR data, AI agent conversations, vitals, and clinical events into an append-only living patient record with source traceability, and is positioned to deliver continuous biometric insights for overdose and suicide prevention. The platform is offered to treatment providers, healthcare systems, and individuals in recovery via an early access program.

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Lionrock Recovery: Lionrock delivers online substance use counseling and group support via telehealth, mirroring Beora's emphasis on continuous engagement beyond in-person treatment episodes.
• Workit Health: Workit Health provides virtual substance use disorder treatment including medication-assisted treatment and therapy. It is a direct competitor in the SUD recovery space with a similar B2B/B2B2C sales motion to providers, payers, and employers.
• Ophelia: Ophelia provides online medication-assisted treatment for opioid dependence and ongoing recovery care. Like MyAlyce, it targets post-discharge retention and aims to be the persistent layer of support across treatment and recovery.
• Boulder Care: Boulder Care delivers telehealth-based opioid use disorder treatment and ongoing recovery support. It directly overlaps MyAlyce's target population and enterprise buyer set (payers and providers) with comparable longitudinal care positioning.
• Eleanor Health: Eleanor Health is a value-based outpatient addiction and mental health provider combining in-person and virtual care. Its population health and longitudinal recovery model is structurally similar to MyAlyce's persistent-record positioning.
• Pelago: Pelago (formerly Quit Genius) is a digital substance use and mental health clinic sold to employers and health plans. It directly competes with Beora in employer- and provider-purchased digital recovery support, with overlapping outcomes focus on relapse prevention.

Broad incumbents

• Spring Health: Spring Health is a mental health benefit platform for employers covering therapy, coaching, and medication management. It is a broad incumbent competing for the same enterprise contracts in the behavioral health category.
• Talkspace: Talkspace is a publicly-traded virtual therapy and psychiatry provider serving consumers, payers, and employers. It is a broad incumbent in digital behavioral health with established enterprise relationships overlapping Beora's buyer set.
• Lyra Health: Lyra Health provides a mental health platform sold to employers, serving therapy, coaching, and medication management. It competes for the same enterprise buyer wallet with broader mental health coverage than Beora's narrower recovery focus.
• Headspace Health: Headspace Health (Ginger + Headspace) is a large incumbent in digital mental health sold to employers and payers. It overlaps with Beora in mental health recovery support but at broader scope and with established enterprise distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/myalyce

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyAlyce